# Filing Detail

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001558370-23-019202
Filing Date
2023-11-17
Accepted
2023-11-17 16:51:18
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q/A | gpcr-20230630x10qa.htm iXBRL | 10-Q/A | 2774629
2 | EX-31.1 | gpcr-20230630xex31d1.htm | EX-31.1 | 15758
3 | EX-31.2 | gpcr-20230630xex31d2.htm | EX-31.2 | 16042
4 | EX-32.1 | gpcr-20230630xex32d1.htm | EX-32.1 | 9952
5 | EX-32.2 | gpcr-20230630xex32d2.htm | EX-32.2 | 10239
6 | GRAPHIC | gpcr-20230630x10qa001.jpg | GRAPHIC | 31575
| Complete submission text file | 0001558370-23-019202.txt |  | 8605764

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | EX-101.SCH | gpcr-20230630.xsd | EX-101.SCH | 42964
8 | EX-101.CAL | gpcr-20230630_cal.xml | EX-101.CAL | 43539
9 | EX-101.DEF | gpcr-20230630_def.xml | EX-101.DEF | 182565
10 | EX-101.LAB | gpcr-20230630_lab.xml | EX-101.LAB | 416071
11 | EX-101.PRE | gpcr-20230630_pre.xml | EX-101.PRE | 312228
53 | EXTRACTED XBRL INSTANCE DOCUMENT | gpcr-20230630x10qa_htm.xml | XML | 1456434

Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41608 | Film No.: 231419542
SIC: 2834 Pharmaceutical Preparations